Given the canonical function of NKG2D, which is to recognize cells undergoing genotoxic stress response, one can speculate that HDAC inhibitor-treated tumor cells expressing NKG2D ligands would be visible to cytolytic cells for destruction, namely by NK and CD8 T cells. This evidence concerns the gene HDAC9 and neoplasm.